Utilizing digital tissue slides from over 1,400 cancer patients, researchers developed DeepHRD, an AI platform trained to predict HRD positivity in breast and ovarian cancers. DeepHRD’s multiresolution decision process mimics pathologists’ protocols, detecting subtle tissue structure changes indicative of HRD status. Unlike visual tests, DeepHRD accurately identifies the HRD biomarker, offering a faster and potentially […]
Tag: biomarker
Enhancing Bioanalysis Through Extreme Robustness
Alderley Analytical is revolutionizing bioanalysis by providing high-quality, interruption-free results to customers, ensuring the safe and efficient development of new drugs. Sally Hannam, Scientific Director at Synexa Life Sciences, praises the Xevo TQ Absolute XR Mass Spectrometer, ACQUITY™ Premier UPLC™ System, and waters_connect™ Software for their unparalleled reproducibility and accuracy in analyzing crashed human plasma. […]
Revolutionizing Medicine with AI-Driven Biomarker Discovery
Predictive Oncology Inc. is at the forefront of revolutionizing medicine through AI-driven biomarker and drug discovery for precision health. With a vast biobank of diverse live-cell tumor specimens, the company is uniquely positioned to drive long-term value and shape the future of cancer treatment and drug development. Collaborating with UPMC Magee-Womens Hospital, Predictive Oncology developed […]
Revolutionizing Medicine with AI-Driven Biomarker Discovery
Predictive Oncology Inc. is at the forefront of revolutionizing medicine through AI-driven biomarker and drug discovery for precision health. With a vast biobank of diverse live-cell tumor specimens, the company is uniquely positioned to drive long-term value and shape the future of cancer treatment and drug development. Collaborating with UPMC Magee-Womens Hospital, Predictive Oncology developed […]
Autoimmunity and Pathogenesis: A Complex Interplay
The immune system’s protective role can backfire with autoimmunity, where it mistakenly attacks the body’s own cells. This phenomenon, known as autoimmunity, leads to a spectrum of diseases ranging from life-threatening organ failure to subtle shifts in biomarker expression without immediate symptoms. Understanding the interplay between autoimmunity and pathogenesis is crucial for developing effective treatments […]
Ultrasensitive DNA Biosensor for Fusobacterium Detection
Fusobacterium nucleatum, a bacterium associated with colorectal cancer, contains the fadA gene, a valuable early diagnostic biomarker. The study highlights the integration of CRISPR/Cas12a system and an improved electrochemiluminescence (ECL) biosensor for ultrasensitive detection. CRISPR/Cas-based sensors face challenges like probe entanglement and reduced enzyme efficiency, but ECL offers superior spatiotemporal control and background noise reduction, […]
University of Houston Secures Funding for Cancer Biomarker Facility Launch
In a groundbreaking development, the University of Houston has secured $3M to establish a state-of-the-art Cancer Immunotherapy Biomarker Core facility. This cutting-edge facility is set to revolutionize biomarker discovery, enhance immunotherapy targeting, and bolster research capabilities throughout Texas. By boosting the state’s standing in cancer research, this initiative promises to drive advancements in patient outcomes […]
